Authors: Zhong Yusheng, Liang Jianhong, Li Xiaoxin, Cheng Yong DOI: 10.3760/cma.j.cn115989-20211116-00633 Published: 2025 -08 -10 Citation Zhong Yusheng, Liang Jianhong, Li Xiaoxin, et al. Research progress in reactivation factors and prevention of retinopathy of prematurity after anti-VEGF therapy[J]. Chin J Exp Ophthalmol, 2025, 43(8):761-765. DOI: 10.3760/cma.j.cn115989-20211116-00633. ABSTRACT [Download PDF] […]
Category: 2025，No. 08
Update on anti-vascular endothelial growth factor treatment for diabetic macular edema
Authors: Zhao Qing, Chen Youxin DOI: 10.3760/cma.j.cn115989-20220211-00051 Published: 2025 -08 -10 Citation Zhao Qing, Chen Youxin. Update on anti-vascular endothelial growth factor treatment for diabetic macular edema[J]. Chin J Exp Ophthalmol, 2025, 43(8):766-776. DOI: 10.3760/cma.j.cn115989-20220211-00051. ABSTRACT [Download PDF] [View Full Text] Diabetic macular edema (DME) is a severe, sight-threatening condition.It mainly […]
Comparison of the effects of two different concentrations of mydriatic drugs in Chinese type 2 diabetic patients: a randomized controlled trial
Authors: Zhou Yifan, Rong Hua, Li Zhiqing, Yu Danyang, Liu Ruoxuan, Li Haoru, Wang Zixun, Wei Ruihua DOI: 10.3760/cma.j.cn115989-20241226-00365 Published: 2025 -08 -10 Citation Zhou Yifan, Rong Hua, Li Zhiqing, et al. Comparison of the effects of two different concentrations of mydriatic drugs in Chinese type 2 diabetic patients: a randomized controlled trial[J]. Chin J Exp Ophthalmol, 2025, […]